Hsp60 as a Novel Target in IBD Management: A Prospect

• Egile Nagusiak: Francesco Cappello (Egilea), Margherita Mazzola (Egilea), Abdo Jurjus (Egilea), Marie-Noel Zeenny (Egilea), Rosalyn Jurjus (Egilea), Francesco Carini (Egilea), Angelo Leone (Egilea), Giuseppe Bonaventura (Egilea), Giovanni Tomasello (Egilea), Fabio Bucchieri (Egilea), Everly Conway de Macario (Egilea), Alberto J. L. Macario (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2019-02-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Inflammatory bowel disease (IBD) encompasses various pathological conditions similar but distinct that share a multifactorial etiology, including involvement of the intestinal barrier function, the immune system, and intestinal microorganisms. Hsp60 is a chaperonin component of the chaperoning syste...